Samsung Biologics will be participating in DCAT Week 2025 in New York City on March 17-20 as part of efforts to further strengthen its global network.
The company will be sharing updates regarding Bio Campus II. Plant 5, the first facility of the new campus, will be operating next month and bring up the company’s total biomanufacturing capacity to 784,000 liters. Samsung Biologics also expanded into the ADC field this year, with a dedicated facility up and running.
The company’s leadership will be hosting a series of meetings with existing and potential clients at the InterContinental New York Barclay to discuss how our manufacturing and development capabilities can support clients’ programs.
Samsung Biologics will be participating in DCAT Week 2025 in New York City on March 17-20 as part of efforts to further strengthen its global network.
The company will be sharing updates regarding Bio Campus II. Plant 5, the first facility of the new campus, will be operating next month and bring up the company’s total biomanufacturing capacity to 784,000 liters. Samsung Biologics also expanded into the ADC field this year, with a dedicated facility up and running.
The company’s leadership will be hosting a series of meetings with existing and potential clients at the InterContinental New York Barclay to discuss how our manufacturing and development capabilities can support clients’ programs.
- CDO
- CGMP
- ADC
- Bio Campus
- IR
- CMO
Share article